Masaaki Odomi

1.4k total citations
53 papers, 1.2k citations indexed

About

Masaaki Odomi is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Masaaki Odomi has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 18 papers in Oncology and 15 papers in Pharmacology. Recurrent topics in Masaaki Odomi's work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Masaaki Odomi is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Masaaki Odomi collaborates with scholars based in Japan, Spain and United States. Masaaki Odomi's co-authors include Kazutaka Higaki, Toshikiro Kimura, Masateru Miyake, Hajime Toguchi, T. Mukai, Keigo Yamada, Naoki Kamada, Gary G. Liversidge, Ken‐ichi Ogawara and Toshio Matsumoto and has published in prestigious journals such as Cancer, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Masaaki Odomi

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaaki Odomi Japan 17 505 239 170 161 152 53 1.2k
Prabhakar Reddy Veerareddy India 24 956 1.9× 251 1.1× 137 0.8× 90 0.6× 128 0.8× 63 1.5k
J.C. Chaumeil France 19 491 1.0× 316 1.3× 50 0.3× 91 0.6× 144 0.9× 53 1.4k
Imre Klebovich Hungary 18 271 0.5× 347 1.5× 101 0.6× 110 0.7× 58 0.4× 120 1.3k
Sorin E. Leucuţa Romania 21 340 0.7× 218 0.9× 90 0.5× 66 0.4× 73 0.5× 80 1.1k
H. Spahn‐Langguth Germany 15 389 0.8× 265 1.1× 330 1.9× 526 3.3× 74 0.5× 43 1.2k
Keith E. Anderson Canada 9 201 0.4× 152 0.6× 129 0.8× 98 0.6× 64 0.4× 18 807
Cordula Stillhart Switzerland 17 522 1.0× 132 0.6× 74 0.4× 167 1.0× 160 1.1× 32 883
Christina Graffner Sweden 17 460 0.9× 129 0.5× 80 0.5× 54 0.3× 70 0.5× 54 1.1k
Ronald D. Schoenwald United States 25 857 1.7× 651 2.7× 194 1.1× 233 1.4× 53 0.3× 74 2.3k
Nurzalina Abdul Karim Khan Malaysia 22 566 1.1× 261 1.1× 103 0.6× 44 0.3× 61 0.4× 49 1.6k

Countries citing papers authored by Masaaki Odomi

Since Specialization
Citations

This map shows the geographic impact of Masaaki Odomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Odomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Odomi more than expected).

Fields of papers citing papers by Masaaki Odomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Odomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Odomi. The network helps show where Masaaki Odomi may publish in the future.

Co-authorship network of co-authors of Masaaki Odomi

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Odomi. A scholar is included among the top collaborators of Masaaki Odomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Odomi. Masaaki Odomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamazaki, Hiroshi, Masateru Miyake, Naoki Kamada, et al.. (2010). Co-administration of Tacrolimus Suppresses Pharmacokinetic Modulation of Multiple Subcutaneously Administered Human Interferon-alpha in Beagle Dogs. Drug Metabolism and Pharmacokinetics. 25(2). 149–154. 3 indexed citations
2.
Kamada, Naoki, Masateru Miyake, Keigo Yamada, et al.. (2008). In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. Journal of Controlled Release. 130(1). 29–37. 58 indexed citations
3.
Kikuchi, Akihiro, Michinori Tanaka, Hiroyuki Sasabe, et al.. (2008). Peptide Derivation of Poorly Absorbable Drug Allows Intestinal Absorption Via Peptide Transporter. Journal of Pharmaceutical Sciences. 98(5). 1775–1787. 16 indexed citations
4.
Miyake, Masateru, Hajime Toguchi, Masaaki Odomi, et al.. (2006). Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption. Journal of Controlled Release. 115(2). 130–133. 20 indexed citations
5.
Miyake, Masateru, Masao Hirota, Hajime Toguchi, et al.. (2006). Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: Utilization of polyamines and bile acids. Journal of Controlled Release. 111(1-2). 27–34. 36 indexed citations
6.
Miyake, Masateru, Naoki Kamada, Yoshikazu Oka, et al.. (2004). Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. Journal of Controlled Release. 99(1). 63–71. 21 indexed citations
7.
Miyanaga, Yohko, Junji Mukai, T. Mukai, Masaaki Odomi, & Takahiro Uchida. (2004). Suppression of the Bitterness of Enteral Nutrients Using Increased Particle Sizes of Branched-Chain Amino Acids (BCAAs) and Various Flavours: a Taste Sensor Study. Chemical and Pharmaceutical Bulletin. 52(4). 490–493. 30 indexed citations
8.
Mitsui, Takao, et al.. (2002). Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. Journal of Neurology. 249(8). 1004–1009. 84 indexed citations
9.
Umehara, Ken, Shoji Kudo, Yukihiro Hirao, et al.. (2000). Oxidative Cleavage of the Octyl Side Chain of 1-(3,4-Dichlorobenzyl)-5-Octylbiguanide (OPB-2045) in Rat and Dog Liver Preparations. Drug Metabolism and Disposition. 28(8). 887–894. 9 indexed citations
10.
Kashiyama, Eiji, Tsuyoshi Yokoi, Masaaki Odomi, & Tetsuya Kamataki. (1999). Stereoselective S-oxidation and reduction of flosequinan in rat. Xenobiotica. 29(8). 815–826. 3 indexed citations
11.
Kudo, Shoji, Masayuki Furukawa, Hiroshi Okumura, et al.. (1998). Percutaneous Absorption and Tissue Distribution of 1-(3,4-dichlorobenzyl)-5-octylbiguanide (OPB-2045) in Rats.. Drug Metabolism and Pharmacokinetics. 13(1). 13–20. 1 indexed citations
12.
Odomi, Masaaki, et al.. (1998). Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation. European Journal of Clinical Pharmacology. 54(3). 253–259. 38 indexed citations
13.
Kudo, Shoji, Ken Umehara, Masaaki Odomi, & Gohachiro Miyamoto. (1998). Metabolism of a New Bactericidal Antiseptic, OPB-2045, in Rats following Subcutaneous Administration.. Drug Metabolism and Pharmacokinetics. 13(4). 346–350. 5 indexed citations
14.
Asaki, Shigeru, et al.. (1996). Phase I Clinical Trial of 13C-Urea Breath Test (C-13UBT).. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 27(3). 607–616. 1 indexed citations
15.
16.
Akiyama, Hitoshi, et al.. (1995). Pharmacokinetics of grepafloxacin (IV):Metabolism after oral administration of grepafloxacin in rats, monkeys and humans. Chemotherapy. 43(1). 131–149. 8 indexed citations
17.
Saito, Shiro, et al.. (1991). Haemodynamics and Pharmacokineticsof Flosequinan (BTS 49 465) after Single and Multiple Oral Administration in Healthy Volunteers.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 22(3). 593–600. 3 indexed citations
18.
Odomi, Masaaki, et al.. (1989). Pharmacokinetics of long-acting capsule of carteolol hydrochloride in a repeated study.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 20(2). 435–440. 1 indexed citations
19.
Odomi, Masaaki, et al.. (1989). Pharmacokinetics and pharmacodynamics of long-acting capsule of carteolol hydrochloride.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 20(2). 427–434. 1 indexed citations
20.
Akiyama, Hitoshi, et al.. (1985). High-performance liquid chromatographic procedure for the determination of a new antithrombotic and vasodilating agent, cilostazol, in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 338(2). 456–459. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prabhakar Reddy Veerareddy Breakdown of academic impact, for papers by J.C. Chaumeil Breakdown of academic impact, for papers by Imre Klebovich Breakdown of academic impact, for papers by Sorin E. Leucuţa Breakdown of academic impact, for papers by H. Spahn‐Langguth Breakdown of academic impact, for papers by Keith E. Anderson Breakdown of academic impact, for papers by Cordula Stillhart Breakdown of academic impact, for papers by Christina Graffner Breakdown of academic impact, for papers by Ronald D. Schoenwald Breakdown of academic impact, for papers by Nurzalina Abdul Karim Khan
Rankless by CCL
2026